Archer-Daniels-Midland Co. 10-K Summary
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended June 30, 1994. Archer-Daniels-Midland Company (ADM) is a global leader in procuring, transporting, storing, processing, and merchandising agricultural commodities. The company operates as a single business segment, processing oilseeds, corn, wheat, and other grains into food and feed ingredients. As of June 30, 1994, the company employed 16,013 people and operated 163 processing plants in the U.S. and 54 foreign plants.
Key Financial Metrics
Note: Specific revenue, net income, and cash flow figures are incorporated by reference from the Annual Shareholders' Report and are not explicitly stated in the provided text. The following metrics are derived from the filing schedules and narrative.
- Capital Expenditures: Approximately $3.3 billion spent over the last five years on new plants, expansions, and acquisitions.
- Property, Plant, and Equipment (PP&E): Total PP&E at cost was $6.66 billion at June 30, 1994, with additions of $531.5 million during the fiscal year.
- Short-Term Borrowings: Maximum outstanding commercial paper was $181.5 million and bank borrowings were $72.3 million during the year. The weighted average interest rate for commercial paper was 3.32%.
- Market Capitalization: Aggregate market value of voting stock held by non-affiliates was approximately $7.3 billion (as of August 22, 1994).
- Research and Development: Technical efforts and expenditures totaled approximately $20.1 million for the fiscal year.
- Environmental Expenditures: $22 million spent in 1994 on pollution control and compliance.
Material Changes and Operational Highlights
- Product Mix: Oilseed products remained the dominant revenue source at 50% of net sales, consistent with the prior year. Corn products accounted for 26%, down slightly from 28% in 1993.
- Expansion: Significant capital additions in 1994 included bioproduct facilities in Decatur, Illinois, and Southport, North Carolina, as well as corn processing expansions in Iowa and Illinois.
- Export Sales: Total export sales represented 12% of net sales, a decrease from 14% in the prior two years.
- Inventory and Working Capital: The company notes that price variations and grain availability at harvest cause wide fluctuations in inventories and short-term borrowings.
Outlook, Risks, and Contingencies
Management Commentary and Outlook: The company continues to expand its bioproducts line, including the production of amino acids (lysine, threonine) and vitamins (riboflavin, biotin). Future production of tryptophan, vitamins C and E, and xanthan gum is expected. Management anticipates environmental expenditures will continue at approximately the present rate with no unusual amounts anticipated for the next two years.
Risks and Contingencies:
- Commodity Volatility: Raw material availability and prices are subject to wide fluctuations due to weather, government policies, and global demand. The company utilizes hedging to minimize price risk.
- Legal Proceedings: The company faces administrative enforcement proceedings from the Illinois EPA regarding permit failures and is a potentially responsible party (PRP) in approximately 20 Superfund clean-up cases. Management believes these will not have a material adverse effect on financial condition.
- Competition: Markets are highly competitive with major competitors including Cargill, ConAgra, and CPC International.
Investor Verification Checklist
- Verify the specific Net Sales and Net Income figures in the Annual Shareholders' Report (pages 24-34), as they are incorporated by reference and not listed in this text.
- Review the Consolidated Statements of Cash Flows to assess liquidity trends given the high capital expenditure environment.
- Monitor the status of the Illinois EPA enforcement proceedings and Superfund liabilities for potential future cost impacts.
- Assess the impact of commodity price fluctuations on margins, as the company operates with thin margins in a highly competitive global market.
- Confirm the progress of bioproduct expansions (vitamins and amino acids) as a driver for future growth beyond traditional commodity processing.